Literature DB >> 23295982

Are risk factors associated with invasive pneumococcal disease according to different serotypes?

Pilar Ciruela1, Núria Soldevila, Laura Selva, Sergi Hernández, Juan Jose Garcia-Garcia, Fernando Moraga, Mariona F de Sevilla, Gemma Codina, Ana Maria Planes, Cristina Esteva, Francis Coll, Neus Cardeñosa, Iolanda Jordan, Joan Batalla, Luis Salleras, Carmen Muñoz-Almagro, Angela Domínguez.   

Abstract

The aim of this study was to investigate risk factors for the most common serotypes of invasive pneumococcal disease (IPD). A total of 293 IPD cases were analyzed in children aged 3-59 mo in a community with intermediate vaccination coverage with the 7-valent pneumococcal vaccine (PCV7). IPD cases were reviewed during 2007-2009 in two pediatric hospitals in Catalonia (Spain). A multivariate analysis using unconditional logistic regression was performed to estimate the adjusted odds ratio. PCV7 coverage was 45.4%. Pneumonia with empyema (64.5%) was the most frequent clinical manifestation. The most common serotypes were: serotype 1 (21.2%), 19A (16.0%), 3 (12.6%) and 7F/A (6.8%). 70.0% of serotypes found were included in the 13-valent conjugate vaccine (PCV13), 39.2% in the 10-valent conjugate vaccine and 8.1% in the PCV7. PCV7 was protective in IPD cases due to PCV7-serotypes (aOR: 0.15, 95% CI:0.04-0.55). Serotype 1 was positively associated with attending day care or school (aOR: 3.55, 95% CI: 1.21-10.38) and age 24-59 mo (aOR: 7.70, 95% CI:2.70-21.98). Serotype 19A was positively associated with respiratory infection in the previous month (aOR: 2.26, 95% CI: 1.03-4.94), non-penicillin susceptible IPD (aOR: 1.89, 95% CI:1.13-3.16) and negatively associated with age 24-59 mo (aOR: 0.19, 95% CI:0.09-0.41). Serotype 3 was positively associated with vaccination (aOR: 4.87, 95% CI:2.05-11.59). No factors were associated with serotype 7F/A. Vaccination with pneumococcal vaccines including more serotypes may reduce the risk of disease in our setting.

Entities:  

Keywords:  Streptococcus pneumoniae; invasive pneumococcal disease; pneumococcal conjugate vaccine; risk factors; serotypes

Mesh:

Substances:

Year:  2013        PMID: 23295982      PMCID: PMC3891733          DOI: 10.4161/hv.23270

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  36 in total

1.  Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.

Authors:  Angela B Brueggemann; David T Griffiths; Emma Meats; Timothy Peto; Derrick W Crook; Brian G Spratt
Journal:  J Infect Dis       Date:  2003-04-04       Impact factor: 5.226

2.  [Vaccination schedule of the Spanish Association of Pediatrics: recommendations 2004].

Authors: 
Journal:  An Pediatr (Barc)       Date:  2004-05       Impact factor: 1.500

3.  Dot blot assay for the serotyping of pneumococci.

Authors:  A Fenoll; I Jado; D Vicioso; J Casal
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

Authors:  W P Hausdorff; J Bryant; C Kloek; P R Paradiso; G R Siber
Journal:  Clin Infect Dis       Date:  2000-01       Impact factor: 9.079

5.  Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR.

Authors:  L Selva; P Ciruela; C Esteva; M F de Sevilla; G Codina; S Hernandez; F Moraga; J J García-García; A Planes; F Coll; I Jordan; N Cardeñosa; J Batalla; L Salleras; A Dominguez; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

6.  Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children.

Authors:  T Smith; D Lehmann; J Montgomery; M Gratten; I D Riley; M P Alpers
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

7.  Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen.

Authors:  K Sjöström; C Spindler; A Ortqvist; M Kalin; A Sandgren; S Kühlmann-Berenzon; B Henriques-Normark
Journal:  Clin Infect Dis       Date:  2006-01-17       Impact factor: 9.079

8.  Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America.

Authors:  O S Levine; M Farley; L H Harrison; L Lefkowitz; A McGeer; B Schwartz
Journal:  Pediatrics       Date:  1999-03       Impact factor: 7.124

9.  Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses.

Authors:  P E Kim; D M Musher; W P Glezen; M C Rodriguez-Barradas; W K Nahm; C E Wright
Journal:  Clin Infect Dis       Date:  1996-01       Impact factor: 9.079

10.  Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited.

Authors:  Pernille Martens; Signe Westring Worm; Bettina Lundgren; Helle Bossen Konradsen; Thomas Benfield
Journal:  BMC Infect Dis       Date:  2004-06-30       Impact factor: 3.090

View more
  4 in total

Review 1.  Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.

Authors:  M A Fletcher; H-J Schmitt; M Syrochkina; G Sylvester
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-23       Impact factor: 3.267

2.  Retrospective study of prognostic factors in pediatric invasive pneumococcal disease.

Authors:  Nan-Chang Chiu; Hsin Chi; Chun-Chih Peng; Hung-Yang Chang; Daniel Tsung-Ning Huang; Lung Chang; Wei-Te Lei; Chien-Yu Lin
Journal:  PeerJ       Date:  2017-01-25       Impact factor: 2.984

3.  Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013.

Authors:  Claire von Mollendorf; Cheryl Cohen; Stefano Tempia; Susan Meiring; Linda de Gouveia; Vanessa Quan; Sarona Lengana; Alan Karstaedt; Halima Dawood; Sharona Seetharam; Ruth Lekalakala; Shabir A Madhi; Keith P Klugman; Anne von Gottberg
Journal:  Emerg Infect Dis       Date:  2016-02       Impact factor: 6.883

4.  Co-Transcriptomes of Initial Interactions In Vitro between Streptococcus Pneumoniae and Human Pleural Mesothelial Cells.

Authors:  Claire J Heath; Maria del Mar Cendra; Alastair Watson; Jean-Philippe Auger; Anish Pandey; Paddy Tighe; Myron Christodoulides
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.